Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Unknown 39 enrolled National Institute of Medical Sciences and Nutrition Salvador Zubiran

NaSingle-groupOpen-labelTreatment

Summary

This study seeks to investigate whether non-selective beta blocker treatment decreases intestinal permeability in cirrhotic patients by altering the expression of genes encoding intercellular junction proteins.

Timeline

Start: 2015-05
Primary completion: 2020-01
Completion: 2020-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Propranolol	Small molecule	20 mg	Oral

Evaluation of Intestinal Permeability in Cirrhotic Patients Before and After Treatment With Non-selective Beta Blocker (Propranolol)

Summary

Timeline

Drugs

Indications